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Introduction
HIV/HCV coinfection may have important implications
for therapeutic and evolving plans. The Knowledge of its
epidemiological, clinical features may help to anticipate
needs and improve care. The aim of the Study was to
determine the epidemic profile of patients co- infected by
hepatitis C virus and HIV.
Materials and methods
A retrospective study was conducted in the infectious
department diseases between 2003 and 201 3, were
included all patients treated for HIV and HCV with posi-
tive serology (ELISA positive). Data were collected on
computer files (Nadis) and analyzed on Epi Info.
Results
We collected 147 patients with HIV/HCV coinfection
(4% of the total workforce). The average age was 40 ± 10
years, males predominated (4H/1F). Intravenous drug use
was found in 29.25 % of patients. At the moment of diag-
nosis of the coinfection, 64 patients (43.5%) were in cate-
gory C (CDC) . Antiretroviral therapy was prescribed for
131 patients (89%). The viral RNA research by RT-PCR
and the genotyping were performed in 39 patients (27 %).
The RNA HCV PCR was positive in 28 cases (19 %). The
most frequent viral genotypes were 1a and 1b with
14 cases (50%). The IL28B performed in 8 patients had
type CC (2 cases), C/T (3 cases), TT (1 case). Liver func-
tion tests were normal in 116 cases; liver cytolysis was
found in 31 cases. The liver ultrasound was normal
(80 cases) or showed lesions of chronic liver disease
(30 cases) or ascites (10 cases). Ten patients undergoing
treatment with pegylated interferon and ribavirin. Two
patients who completed treatment were non-responders.
79 patients (54%) are being used and 27 cases died (18%).
Conclusion
The HIV/HCV co-morbidity is a challenge in support of
PLHIV. Currently, free access to treatment and explora-
tions of hepatitis C in Morocco as part of a health program
(RAMED) is an important step whose impact needs to be
evaluated.
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